Both in Biotechnology
Voyager Therapeutics vs Armata Pharmaceuticals
Over the past year VYGR returned −60.1% and ARMP returned −36.0%; their daily moves had a correlation of 0.19.
VYGR −60.1% ARMP −36.0%Growth of $1, one year, split-adjusted
| Metric | VYGR | ARMP |
|---|---|---|
| Price | $1.83 | $3.09 |
| Market cap | $112.8M | $114.9M |
| Today | +2.81% | +8.42% |
| 1 month | −25.6% | −15.6% |
| 6 months | −53.1% | −67.0% |
| Year to date | −53.4% | −50.8% |
| 1 year | −60.8% | −37.1% |
| Revenue growth (YoY) | −39.1% | +15.7% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −773.2% | 2953.8% |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | 20.7× |
| Net cash | $116.3M | -$259.6M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 115.8% |
| Short % of float | 7.8% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).